ICER (the Institute for Clinical and Economic Review) has added members to three independence appraisal councils: Midwest CEPAC (Midwest Comparative Effectiveness Public Advisory Council), CTAF (the California Technology Assessment Forum), and New England CEPAC (the New England Comparative Effectiveness Public Advisory Council). The diverse backgrounds of the new members range include experience in patient advocacy, health economics and outcomes research, healthcare consulting, law, and clinical practice.
According to ICER President Dr. Steven Pearson, “Weighing the value of a medical intervention is a multi-faceted process, spanning comparative clinical effectiveness, long-term cost-effectiveness, as well as broader contextual considerations that are harder to quantify,” adding, “Our independent evidence appraisal councils play a vital role in ICER’s work, representing an open, transparent forum to receive input from patients, clinical experts, and other stakeholders, and then to deliberate and vote on the evidence regarding a treatment’s net health benefit and economic value for patients and the health system. The discussions during each of ICER’s public meetings reflect the dedication, thoughtfulness, and rigor of each member of these councils, and we look forward to the perspectives that this year’s distinguished new members will add.” Read more here.
(Source: ICER, 3/18/21)